ASN
PRME icon

Advisory Services Network’s Prime Medicine PRME Stock Holding History

Advisory Services Network’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,153
Closed -$10.2K – 3097
2023
Q4 		$10.2K Buy
+1,153
New +$8.88K ﹤0.01% 2851

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Advisory Services Network's PRME Position: Q1 2024 in Review

Advisory Services Network sold out of Prime Medicine (PRME) in Q1 2024, closing a stake of 1,153 shares — an estimated $10.2K sold.

Advisory Services Network first reported a position in PRME in Q4 2023 and held it in 1 quarter. The position peaked at $10.2K in Q4 2023. 115 funds tracked by Wall St. Rank hold PRME as of Q1 2024.

  • Advisory Services Network reported no remaining Prime Medicine position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 1,153 Prime Medicine shares in Q1 2024, an estimated $10.2K.
  • Advisory Services Network first reported a position in Prime Medicine in Q4 2023 and held it in 1 quarter.
  • Advisory Services Network's Prime Medicine position peaked at $10.2K in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.